abstract |
Described is modulation of vascular permeability (VP) by Src tyrosine kinase or Yes tyrosine kinase, or by selective inhibition of Src family tyrosine kinase activity, and a pharmaceutical composition comprising a therapeutically effective VP modulating amount of Src and / or Yes tyrosine kinase proteins, or a mixture thereof in a therapeutically acceptable carrier. |